Luye Pharma Group (LUP) Income Statement
Luye Pharma Group Income Statement
Last quarter (Q2 2026), Luye Pharma Group's total revenue was $3.00B, a decrease of 2.36% from the same quarter last year. In Q2, Luye Pharma Group's net income was $390.49M. See Luye Pharma Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 6.31B | $ 6.06B | $ 6.14B | $ 5.98B | $ 5.20B | |
| $ 4.16B | $ 4.04B | $ 4.20B | $ 4.14B | $ 3.40B | |
| $ 2.92B | $ 2.90B | $ 3.29B | $ 3.26B | $ 2.96B | |
| Depreciation and Amortization | $ 839.49M | $ 790.67M | $ 701.85M | $ 671.31M | $ 581.98M |
| $ 2.06B | $ 1.92B | $ 2.08B | $ 1.81B | $ 906.88M | |
| $ 1.24B | $ 1.15B | $ 917.88M | $ 880.62M | $ 437.96M | |
| $ -298.24M | $ -308.03M | $ -217.78M | $ -210.86M | $ -357.36M | |
| $ 944.64M | $ 839.22M | $ 700.10M | $ 669.76M | $ -74.56M | |
| $ 618.75M | $ 471.89M | $ 532.61M | $ 604.81M | $ -134.39M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.16 | $ 0.13 | $ 0.14 | $ 0.17 | $ -0.04 |
| Diluted EPS | $ 0.16 | $ 0.13 | $ 0.14 | $ 0.17 | $ -0.04 |
| Weighted Average Shares Outstanding | 3.90B | 3.76B | 3.73B | 3.48B | 3.45B |
| Weighted Average Shares Outstanding (Diluted) | 3.90B | 3.76B | 3.73B | 3.48B | 3.45B |
Currency in CNY
